Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Clinical Interventions in Aging|September 21, 2010
Optimal management of sarcopeniaLouise A Burton, Deepa SumukadasClinical Endocrinology|June 25, 2011
Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people?Louise A Burton, Marion E T McMurdo, Allan D StruthersThe American Journal of Medicine|May 28, 2013
Effect of spironolactone on physical performance in older people with self-reported physical disabilityLouise A Burton, Deepa Sumukadas, Miles D Witham, et al.BMC Research Notes|June 17, 2018
Acceptability and feasibility of magnetic femoral nerve stimulation in older, functionally impaired patientsLouise A Beveridge, Rosemary J G Price, Louise A Burton, et al.Age and Ageing|December 20, 2015
Hospital-acquired pneumonia incidence and diagnosis in older patientsLouise A Burton, Rosemary Price, Karen E Barr, et al.Plos One|November 14, 2023
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trialTufail Bashir, Marcus Achison, Simon Adamson, et al.Plos One|October 20, 2023
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trialChristos Rossios, Tufail Bashir, Marcus Achison, et al.Plos One|August 2, 2024
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trialAlvin Shrestha, Tufail Bashir, Marcus Achison, et al.Journal of Cachexia, Sarcopenia and Muscle|February 17, 2022
Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial, Marcus Achison, Simon Adamson, et al.Pageof 1